Patients with HbA@c < @ % ( @ mmol/mol ) were discharged on their preadmission diabetes therapy , HbA@c between @ and @ % ( @-@ @ mmol/mol ) were discharged on a preadmission regimen plus glargine at @ % of hospital daily dose , and HbA@c > @ % were discharged on oral antidiabetes agents ( OADs ) plus glargine or basal bolus regimen at @ % of inpatient dose .